共 50 条
- [45] Pre-clinical evaluation of LYS6KAKT1, a novel, highly selective, orally bioavailable dual inhibitor of p70 S6 Kinase and AKT currently in phase I clinical trials for cancer EJC SUPPLEMENTS, 2010, 8 (07): : 28 - 28
- [48] Oral Administration of Apigenin Inhibits Metastasis through AKT/P70S6K1/MMP-9 Pathway in Orthotopic Ovarian Tumor Model INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (06): : 7271 - 7282